Volcano nudges revenue higher in Q2, but swings to a loss

Volcano ($VOLC) grew its 2013 second-quarter revenue to $101.3 million, a 6% hike over the same period last year. But the California maker of intravascular imaging, diagnostic and therapeutic devices lost $2.4 million, due in part to costs relating to a 2012 debt offering. Volcano said it experienced double-digit sales gains in its fractional flow reserve disposables business in Europe and Japan in particular. And Volcano noted its intravascular imaging revenue met expectations. Item

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.